The CMV inSIGHT™ T Cell Immunity Panel measures the strength of T cell responses to Cytomegalovirus (CMV) specific antigens. It evaluates and reports the activity of CD4 and CD8 T cell responses independently.  Effective T cell immunity against CMV is a factor in controlling CMV viral latency.  CMV can affect patients with weakened immune systems and is a common risk factor in patients following solid organ or hematopoietic stem cell transplant.

Dk green Sodium heparin (Na hep), no gel

• Collect Monday through Friday only
• Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times, to prevent clotting
• Tube must be at least ¾ full to maintain proper ratio of blood to anticoagulant

Dk green Sodium heparin (Na hep), no gel

Dk green Sodium heparin (Na hep), no gel, 4mL x 2

Dk green Sodium heparin (Na hep), no gel, 4mL x 2

Ambient (strict) - 32 hours

Refrigerated - NO

Frozen - NO

Must be received within 32 hours from collection

• Whole blood received after stability (32 hours after collection)
• Whole blood received cold or frozen
• Tubes received less than 3/4 full
• Specimens received in lithium heparin, ACD or EDTA anticoagulants.

Flow Cytometry

See report

Medical necessity